|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 118.96 CHF | -0.07% |
|
+2.04% | +8.74% |
| 05-19 | Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case | MT |
| 05-19 | Novo Nordisk Says 'Disappointed' by US Supreme Court Decision in Medicare Drug Pricing Case | MT |
| Capitalization | 287B 248B 227B 215B 396B 27,833B 406B 2,707B 1,054B 13,103B 1,079B 1,056B 45,753B | P/E ratio 2026 * |
20.9x | P/E ratio 2027 * | 17.9x |
|---|---|---|---|---|---|
| Enterprise value | 320B 276B 253B 239B 440B 30,958B 451B 3,011B 1,172B 14,574B 1,200B 1,174B 50,890B | EV / Sales 2026 * |
5.6x | EV / Sales 2027 * | 5.21x |
| Free-Float |
91.66% | Yield 2026 * |
3.02% | Yield 2027 * | 3.1% |
Last Transcript: Novartis AG
Trading Novartis AG
| 1 day | -0.07% | ||
| 1 week | +2.04% | ||
| Current month | +2.83% | ||
| 1 month | +0.81% | ||
| 3 months | -5.76% | ||
| 6 months | +18.68% | ||
| Current year | +8.74% |
| 1 week | 115.72 |  | 119.66 |
| 1 month | 108.24 | | 119.66 |
| Current year | 107.68 | | 131 |
| 1 year | 91.2 | | 131 |
| 3 years | 81.1 | | 131 |
| 5 years | 72.84 | | 131 |
| 10 years | 65.09 | | 131 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 16/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 68 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 10.4% | 121 M€ | |
| +4.91% | 5.57% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.07% | +2.04% | +27.75% | +30.62% | 287B | |
| +3.37% | +3.19% | +35.27% | +130.89% | 911B | |
| +0.47% | +2.56% | +50.83% | +44.74% | 554B | |
| +2.08% | +2.84% | +15.10% | +47.31% | 378B | |
| +1.19% | +0.40% | +24.15% | +11.99% | 333B | |
| -0.09% | +0.82% | +33.21% | +15.31% | 288B | |
| +1.49% | +1.66% | +47.92% | -1.08% | 282B | |
| -0.37% | -4.09% | -37.09% | -51.36% | 198B | |
| +1.96% | -1.65% | +19.90% | +48.04% | 179B | |
| +0.64% | -3.29% | +22.93% | +65.51% | 162B | |
| Average | +0.28% | +0.91% | +24.00% | +34.20% | 357.15B | |
| Weighted average by Cap. | +0.18% | +1.89% | +29.41% | +52.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.14B 49.28B 45.15B 42.66B 78.65B 5,532B 80.63B 538B 210B 2,604B 214B 210B 9,094B | 60.59B 52.26B 47.87B 45.24B 83.4B 5,866B 85.49B 571B 222B 2,762B 227B 223B 9,643B |
| Net income | 14.15B 12.2B 11.18B 10.56B 19.47B 1,370B 19.96B 133B 51.88B 645B 53.09B 51.96B 2,252B | 15.69B 13.53B 12.39B 11.71B 21.59B 1,519B 22.13B 148B 57.51B 715B 58.86B 57.61B 2,496B |
| Net Debt | 32.28B 27.84B 25.5B 24.1B 44.43B 3,125B 45.55B 304B 118B 1,471B 121B 119B 5,137B | 28.28B 24.39B 22.34B 21.11B 38.92B 2,738B 39.9B 266B 104B 1,289B 106B 104B 4,500B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/05/26 | 119.18 CHF | +0.12% | 363,470 |
| 19/05/26 | 119.04 CHF | +1.57% | 2,125,954 |
| 18/05/26 | 117.20 CHF | +0.45% | 2,175,069 |
| 15/05/26 | 116.68 CHF | -0.10% | 2,888,106 |
| 13/05/26 | 116.80 CHF | +0.78% | 2,234,932 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition